The Journal of Clinical and Aesthetic Dermatology
JCAD's audio platform provides interviews with leading experts in the dermatology field.
Episodes
53 episodes
Ted Lain, MD: Long-Term Results of Deuruxolitinib for Alopecia Areata
Ted Lain, MD, a board-certified dermatologist at Sanova Dermatology in Austin, Texas, shares his extensive experience with deuruxolitinib (Leqselvi) for the treatment of patients with moderate-to-severe alopecia areata. Drawing on 5 years of lo...
•
7:51
James Del Rosso, DO: JCAD February 2026 Issue Highlights
James Del Rosso, DO, the Clinical Editor-in-Chief of the Journal of Clinical and Aesthetic Dermatology, discusses highlights from new research published in the February 2026 issue of JCAD.
•
24:22
James Del Rosso, DO, and David Cotter, MD, PhD: The Use of Gene-Expression Profile Testing for Effective Atopic Dermatitis Treatment
James Del Rosso, DO, and David Cotter, MD, PhD, discuss using gene expression profile testing, such as the AdvanceAD-Tx test, to provide effective treatment for patients with atopic dermatitis. AdvanceAD-Tx allows clinicians to match therapy ba...
•
19:29
Amy McMichael, MD: Eight-Week Outcomes With Deuruxolitinib in Alopecia Areata
Amy McMichael, MD, a clinical professor and chair of the Department of Dermatology at Wake Forest School of Medicine, discusses deuruxolitinib for patients with alopecia areata. She highlights its 8-week efficacy compared to placebo in clinical...
•
6:02
Graham Litchman, DO, MS: Understanding Long-Term Treatment Success in a Patient With Psoriasis
Graham Litchman, DO, MS, a board-certified dermatologist at Vivida Dermatology in Las Vegas, Nevada, discusses a patient case involving a 54-year-old female patient with psoriasis who did not respond well to conventional treatments or systemic ...
•
8:39
James Del Rosso, DO: JCAD January 2026 Issue Highlights
James Del Rosso, DO, the Clinical Editor-in-Chief of the Journal of Clinical and Aesthetic Dermatology, discusses highlights from new research published in the January 2026 issue of JCAD.
•
22:36
Aaron Farberg, MD: Real-World Experiences in Alopecia Areata Treatment
Dr. Aaron Farberg, a board-certified dermatologist and founder of Bear Dermatology in Dallas, Texas, discusses the evolving treatment landscape for alopecia areata with a focus on Janus kinase inhibitors and how he has used this type of treatme...
•
5:18
Arash Mostaghimi, MD, MPH, FAAD: Considerations for the Use of Deuruxolitinib in Patients with Alopecia Areata
Dr. Mostaghimi discusses the speed and depth of efficacy of deuruxolitinib for providing hair regrowth in patients with severe alopecia areata.
•
4:35
James Del Rosso, DO: JCAD November 2025 Issue Highlights
Dr. Del Rosso, Clinical Editor-in-Chief of the Journal of Clinical and Aesthetic Dermatology, discusses highlights from new research published in the November 2025 issue of JCAD.
•
20:01
Extended-cut Podcast—James Del Rosso, DO, and David G. Cotter, MD, PhD: Targeting the IL-31 Neuroimmune Pathway for Treating Prurigo Nodularis
Drs. Del Rosso and Cotter discuss advances in the molecular understanding of prurigo nodularis, which have enabled the development of targeted pharmaceuticals that treat the root of this condition.
•
21:52
James Del Rosso, DO: JCAD October 2025 Issue Highlights
Dr. Del Rosso, Clinical Editor-in-Chief of the Journal of Clinical and Aesthetic Dermatology, discusses highlights from new research published in the October 2025 issue of JCAD.
•
18:53
David G. Cotter, MD, PhD: The Ideal Patient Candidate for Deuruxolitinib for Patients with Alopecia Areata
Dr. Cotter discusses providing rapid hair regrowth in patients with alopecia areata.
•
1:45
David G. Cotter, MD, PhD: Utilizing the 31-gene Expression Profile Test in Patients with Melanoma
Dr. Cotter discusses results of an expert consensus panel of the 31-gene expression profile test for patients with Melanoma.
•
8:53
David G. Cotter, MD, PhD: Providing Regrowth of Hair in Patients with Alopecia Areata
Dr. Cotter discusses providing effective treatment for patients with alopecia areata
•
6:33
James Del Rosso, DO: JCAD September 2025 Issue Highlights
Dr. Del Rosso, Clinical Editor-in-Chief of the Journal of Clinical and Aesthetic Dermatology, discusses highlights from new research published in the September 2025 issue of JCAD.
•
20:38
James Del Rosso, DO: JCAD August 2025 Issue Highlights
Dr. Del Rosso, Clinical Editor-in-Chief of the Journal of Clinical and Aesthetic Dermatology, discusses highlights from new research published in the August 2025 issue of JCAD.
•
19:21
JCAD Dialogues and Reviews: Updates in Photoprotection and Recent Indication Expansions in Psoriasis and Rosacea
Dr. Del Rosso discusses advancements in photoprotection formulations, as well as recent FDA approvals that have expanded treatment options for rosacea and psoriasis.
•
8:55
James Del Rosso, DO: JCAD June 2025 Issue Highlights
Dr. Del Rosso, Clinical Editor-in-Chief of the Journal of Clinical and Aesthetic Dermatology, discusses highlights from new research published in the June 2025 issue of JCAD.
•
16:21
Extended-cut Podcast— Naiem Issa, MD, PhD, and Christopher Bunick, MD, PhD: Mechanisms of Dupilumab-associated Arthralgia in Patients with Atopic Dermatitis
In this extended cut from JCAD’s recent Journal Review video series, Drs. Issa and Bunick dive into the possible mechanistic explanations behind arthralgia associated with dupilumab, which was detailed in a case series by Drs. Issa and Bunick a...
•
24:09
James Del Rosso, DO: JCAD May 2025 Issue Highlights
Dr. Del Rosso, Clinical Editor-in-Chief of the Journal of Clinical and Aesthetic Dermatology, discusses highlights from new research published in the May 2025 issue of JCAD.
•
15:01
James Del Rosso, DO: JCAD April 2025 Issue Highlights
Dr. Del Rosso, Clinical Editor-in-Chief of the Journal of Clinical and Aesthetic Dermatology, discusses highlights from new research published in the April 2025 issue of JCAD.
•
17:58
James Del Rosso, DO: JCAD February 2025 Issue Highlights
Dr. Del Rosso, Clinical Editor-in-Chief of the Journal of Clinical and Aesthetic Dermatology, discusses highlights from new research published in the February 2025 issue of JCAD.
•
12:20
JCAD Dialogues and Reviews: Highlighting a Vitiligo Roundtable Discussion in JCAD
Dr. James Del Rosso discusses a recent supplement that reviews insights about the challenges faced by both patients and clinicians in managing vitiligo.
•
3:24
